These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 788388)

  • 1. [Problems of specific secretory antiviral immunity].
    Shvartsman IaS
    Usp Sovrem Biol; 1976; 81(3):429-44. PubMed ID: 788388
    [No Abstract]   [Full Text] [Related]  

  • 2. Secretory antibodies in respiratory virus infections.
    Petrescu A
    Virologie; 1984; 35(2):133-8. PubMed ID: 6330974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunoglobulins in virus disease.
    Blandford G; Heath RB
    Mod Trends Med Virol; 1970; 2(0):51-77. PubMed ID: 4365750
    [No Abstract]   [Full Text] [Related]  

  • 4. [Circulating and secretory antibodies in mice after administration of influenza virus by various routes].
    Wilczyński J; Loza-Tulimowska M; Semkow R
    Med Dosw Mikrobiol; 1979; 31(4):239-44. PubMed ID: 544981
    [No Abstract]   [Full Text] [Related]  

  • 5. [Secretory and serum response after intranasal influenza vaccination with A/Victoria attenuated live virus].
    Crifò S; Filiaci F; Pelosio A; Rocchi G
    Boll Soc Ital Biol Sper; 1978 Jun; 54(11):1021-6. PubMed ID: 743410
    [No Abstract]   [Full Text] [Related]  

  • 6. Mucosal (SIgA) and serum (IgG) immunologic responses in young adults following intranasal administration of one or two doses of inactivated, trivalent anti-influenza vaccine.
    Greenbaum E; Engelhard D; Levy R; Schlezinger M; Morag A; Zakay-Rones Z
    Vaccine; 2004 Jun; 22(20):2566-77. PubMed ID: 15193382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunologic and virologic aspects of secretory immune system in human respiratory tract.
    Ogra PL; Morag A
    Dev Biol Stand; 1975; 28():129-44. PubMed ID: 47823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and immunological characteristics of the emulsion form of inactivated influenza vaccine delivered by oral immunization.
    Avtushenko SS; Sorokin EM; Zoschenkova NY; Zacharova NG; Naichin AN
    J Biotechnol; 1996 Jan; 44(1-3):21-8. PubMed ID: 8717382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aerosol and nasal delivery of vaccines and antiviral drugs against seasonal and pandemic influenza.
    Wong JP; Christopher ME; Viswanathan S; Schnell G; Dai X; Van Loon D; Stephen ER
    Expert Rev Respir Med; 2010 Apr; 4(2):171-7. PubMed ID: 20406083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccinology and selected virus diseases.
    Dull HB
    Adv Intern Med; 1971; 17():143-70. PubMed ID: 4950244
    [No Abstract]   [Full Text] [Related]  

  • 11. [Immunologic reactions following influenza virus vaccination].
    Süss J; Schmidt S; Groh A; Vogt KH; Schmidt J
    Z Gesamte Hyg; 1985 Mar; 31(3):149-53. PubMed ID: 4013413
    [No Abstract]   [Full Text] [Related]  

  • 12. Type I IFN is a powerful mucosal adjuvant for a selective intranasal vaccination against influenza virus in mice and affects antigen capture at mucosal level.
    Bracci L; Canini I; Puzelli S; Sestili P; Venditti M; Spada M; Donatelli I; Belardelli F; Proietti E
    Vaccine; 2005 Apr; 23(23):2994-3004. PubMed ID: 15811645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Characteristics of influenza immunity and prospects of achieving virus-specific prevention of influenza].
    Shvartsman IaS; Tsybul'skaia NV; Ispolatova AV
    Usp Sovrem Biol; 1982; 94(3):446-60. PubMed ID: 6186100
    [No Abstract]   [Full Text] [Related]  

  • 14. Neutralizing influenza antibodies, IgA and total protein in the nasopharyngeal secretions of subjects vaccinated by nasal route with the inactivated influenza vaccine prepared in the "Stefan S. Nicolau" Institute of Virology.
    Petrescu A; Mihail A; Samuel I; Teodosiu O; Isaia G; Ganea E; Motaş C
    Virologie; 1979; 30(2):109-15. PubMed ID: 111408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective immunity against influenza H5N1 virus challenge in mice by intranasal co-administration of baculovirus surface-displayed HA and recombinant CTB as an adjuvant.
    Prabakaran M; Velumani S; He F; Karuppannan AK; Geng GY; Yin LK; Kwang J
    Virology; 2008 Oct; 380(2):412-20. PubMed ID: 18786689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Anticipating "flu mist"--soon a must].
    Gnehm HE
    Schweiz Med Wochenschr; 1998 Dec; 128(51-52):2023-6. PubMed ID: 10025000
    [No Abstract]   [Full Text] [Related]  

  • 17. Serum and mucosal immunologic responses in children following the administration of a new inactivated intranasal anti-influenza vaccine.
    Greenbaum E; Furst A; Kiderman A; Stewart B; Levy R; Schlesinger M; Morag A; Zakay-Rones Z
    J Med Virol; 2001 Sep; 65(1):178-84. PubMed ID: 11505461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical and immunologic effects following oral immunization against influenza in children in day care and infection susceptible young children].
    Wiersbitzky S; Bruns R; Seidel E; Tischner H; Broda J; Gocht A; Dorn U; Luther P
    Padiatr Grenzgeb; 1990; 29(1):43-51. PubMed ID: 2342818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reliability of the serological method of examination as a basis for diagnosis of associated respiratory virus infections.
    Mayorova LP; Mikutskaya BA; Morozenko MA; Sokolova LA; Boldasov VK
    J Hyg Epidemiol Microbiol Immunol; 1976; 21(3):314-31. PubMed ID: 188945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Occurrence of influenza specific antibodies in the lung after oral immunization in mice.
    Bergmann KC; Waldman RH
    Poumon Coeur; 1982; 38(5):289-92. PubMed ID: 7155999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.